Subscribe

Tiffany Richards, PhD, ANP-BC

Authored Items

Daratumumab Offers New Hope for Patients with Multiple Myeloma
By Rebecca Lu, MS, FNP,; Tiffany Richards, PhD, ANP-BC
TON - September 2017, Vol 10, No 5 — September 10, 2017
Multiple Myeloma
Historically, therapies for patients with MM included high-dose dexamethasone, alkylating agents, and autologous stem cell transplantation. In the late 1990s, a new era in myeloma treatment began with the introduction of the immunomodulatory drug (IMiD) thalidomide, followed by subsequent development of the proteasome inhibitors bortezomib and carfilzomib, and the next-generation IMiDs lenalidomide and pomalidomide. Read More ›
How to Handle Survivorship Care for Multiple Myeloma
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards insists on the importance of survivorship care in patients with multiple myeloma and explains how to make sure patients stay as healthy as possible for as long as possible. Read More ›
How to Utilize New Mutliple Myeloma Drugs
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards is excited about all the new multiple myeloma treatments that are being introduced, but understands that the question of how to best utilize these drugs still remains to be answered. Read More ›
Preparing Your Patients for Side Effects
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards stresses the importance of educating patients about side effects and what to do when these side effects begin to present. Read More ›
Know Your Patients' Baselines
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards shares anecdotes that illustrate why it's important to really know your patients in order to effectively care for them. Read More ›
Meeting the Needs of the Patient
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards discusses the numerous, often unmet, needs of patients with multiple myeloma. Read More ›
Common Questions About Daratumumab
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab. Read More ›
Daratumumab: An Overview
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies. Read More ›
Challenges with Managing Patients with Malignant Diseases
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards explains the difficulties she has encountered in managing patients who have battled myeloma for an extended period of time and have experienced multiple relapses. Read More ›
Keeping Up with Advances in Multiple Myeloma
By Tiffany Richards, PhD, ANP-BC
Conference Correspondent  — April 18, 2017
Hematologic Cancers, Conference Correspondent, ASH
Tiffany Richards identifies the many recources she leverages to stay current on new treatments. Read More ›

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.